Clinical Trial Update: A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating LY3962681 in healthy volunteers and patients with Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• LY3962681 (LY3962681)

Snippet

Sponsor: Prevail Therapeutics | Conditions: Parkinson's Disease | Phase 1 | Status: RECRUITING